Skip to main content
SpringerLink
Log in

Arabinogalactan- and dextran-induced ear inflammation in mice: Differential inhibition by H1-antihistamines, 5-HT-serotonin antagonists and lipoxygenase blockers

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Intravenous injection of arabinogalactan or dextran together with pontamine sky-blue dye into mice increased vascular permeability and led to marked blueing of the ears. Arabinogalactan caused a rapidly progressing ear blueing (maximal coloration 20–30 min after injection). This response was suppressed by pretreating the animals with the histamine H1-antihistamines levocabastine and loratadine. In contrast, dextran induced a slowly evolving ear inflammation (maximal coloration 60–90 min after injection), which was blocked by the 5-HT-serotonin antagonists cinanserin, metergoline and ritanserin. Furthermore, the dextran reaction was inhibited by the lipoxygenase (LO)/cyclooxygenase (CO) inhibitors BW540C, BW755C and phenidone and by the specific 5-LO inhibitor AA-861. Both arabinogalactan and dextran responses were inhibited by aprotinin, a kallikrein inhibitor, and the mixed H1/5-HT antagonists astemizole and azatadine. The inflammogenic activity of the polysaccharides was not affected by administration of the CO inhibitors indomethacin and suprofen, the thromboxane synthetase inhibitor dazoxiben, the H2-antihistamines cimetidine and ranitidine, the anticholinergics isopropamide or the PAF-antagonist L-652,731.

These data indicate the existence of distinctive endogenous molecules that mediate the pinnal extravasation reaction to both polysaccharides: histamine for arabinogalactan, serotonin and lipoxygenase-derived arachidonic acid metabolites for dextran.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. R. Anderson and E. Hardenbergh,Anaphylactoid reaction of the mouse to dextran. Proc. Soc. exp. Biol. Med.117, 565–567 (1964).

    PubMed  Google Scholar 

  2. W. Richter,Increased vascular permeability in mice induced by dextran. A comparison with the anaphylactoid reaction in rats. Acta pharmac. tox.27, 331–348 (1969).

    Google Scholar 

  3. L. S. Kind, B. Macedo-Sobrinho and D. Ako,Enhanced vascular permeability incuded in mice by larch arabinogalactan. Immunology19, 799–807 (1970).

    PubMed  Google Scholar 

  4. S. I. Ankier and M. L. Neat,Some studies on acute inflammation by dextran in the mouse. Int. Archs. Allergy42, 264–277 (1972).

    Google Scholar 

  5. J. P. van Wauwe and J. G. Goossens,Dextran-induced edema formation in mouse ear: a pharmacological evaluation. Drug Dev. Res.8, 213–218 (1986).

    Google Scholar 

  6. R. A. Stokbroeckx, M. G. Luyckx, J. J. Willems, J. O. Bracke, R. Joossen and J. P. van Wauwe,Levocabastine (R 50 547): the prototype of a chemical series of compounds with specific H 1-antihistaminic activity. Drug Dev. Res.8, 87–93 (1986).

    Google Scholar 

  7. S. I. Ankier and M. L. Whiteside,A simple procedure for the quantitative extraction of extravasated dye in skin tissue. Biochem. Pharmac.18, 2197–2202 (1969).

    Google Scholar 

  8. D. J. Finney, Cambridge University Press, pp. 236–254 (1962).

  9. A. Barnett, L. C. Iorio, W. Kreutner, S. Tozzi, H. S. Ahn and A. Gulbenkian,Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Agents and Actions14, 590–597 (1984).

    PubMed  Google Scholar 

  10. J. E. Leysen, C. J. E. Niemegeers, J. P. Tollenaere and P. M. Laduron,Serotoninergic component of neuroleptic receptors. Nature272, 168–171 (1978).

    PubMed  Google Scholar 

  11. M. Hamon, M. Mallat, A. Herbet, D. L. Nelson, M. Audinot, L. Pichat and J. Glowinski, [3H]Metergoline: a new ligand of serotonin receptors in the rat brain. J. Neurochem.36, 613–626 (1981).

    PubMed  Google Scholar 

  12. J. E. Leysen, W. Gommeren, P. van Gompel, J. Wijnants, P. F. M. Janssen and P. M. Laduron,Receptor binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S 2 antagonist. Mol. Pharmacol.27, 600–611 (1985).

    PubMed  Google Scholar 

  13. F. C. Copp, P. J. Islip and J. E. Tateson,3-N-substituted-amino-1-[3-(trifluoromethyl)phenyl]-2-pyrazolines have enhanced activity against arachidonate 5-lipoxygenase and cyclooxygenase. Biochem. Pharmac.33, 339–340 (1984).

    Google Scholar 

  14. G. A. Higgs, R. J. Flower and J. R. Vane,A new approach to anti-inflammatory drugs. Biochem. Pharmac.28, 1959–1961 (1979).

    Google Scholar 

  15. G. J. Blackwell and R. J. Flower,1-Phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins16, 417–425 (1978).

    PubMed  Google Scholar 

  16. Y. Ashida, T. Saijo, H. Kuriki, H. Makino, S. Terao and Y. Maki,Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor. Prostaglandins26, 955–970 (1983).

    PubMed  Google Scholar 

  17. R. Vogel,Kallikrein inhibitors. InHandbook of Experimental Pharmacology, vol. 25. (Ed. E. G. Erdös) pp. 165–399, Springer-Verlag, New York 1979.

    Google Scholar 

  18. T. J. Williams,Vascular responses and their suppression: vasodilatation and oedema. InThe Pharmacology of Inflammation, vol. 5. (Eds. I. L. Bonta, M. A. Bray, M. J. Parnham) pp. 49–60, Elsevier, Amsterdam 1985.

    Google Scholar 

  19. D. Regoli and J. Barabe,Pharmacology of bradykinin and related kinins. Pharmac. Res.32, 1–46 (1980).

    Google Scholar 

  20. D. A. Owen,Vascular changes during acute inflammatory responses in rat hindpaws. InPerspectives in Inflammation. (Eds. D. A. Willoughby, J. P. Giroud, G. P. Velo) pp. 491–495, MTP, London 1977.

    Google Scholar 

  21. D. A. Owen and D. F. Woodward,Histamine and histamine H 1- and H2-receptor antagonists in acute inflammation. Biochem. Soc. Trans.8, 150–156 (1980).

    PubMed  Google Scholar 

  22. W. G. Spector and D. A. Willoughby,Vasoactive amines in acute inflammation. Ann. N.Y. Acad. Sci.116, 839–846 (1964).

    PubMed  Google Scholar 

  23. H. Bisgaard, J. Kristensen and J. Sondergaard,The effect of leukotriene C 4 and D4 on cutaneous blood flow in humans. Prostaglandins23, 797–801 (1982).

    PubMed  Google Scholar 

  24. N. A. Soter, R. A. Lewis, E. J. Corey and K. F. Austen,Local effects of synthetic leukotrienes (LTC 4, LTD4, LTE4 and LTB4)in human skin. J. invest. Derm.80, 115–119 (1983).

    PubMed  Google Scholar 

  25. A. Veno, K. Tanaka, M. Katori, M. Hayashi and Y. Arai,Species difference in increased vascular permeability by synthetic leukotriene C 4 and D4. Prostaglandins21, 637–647 (1981).

    PubMed  Google Scholar 

  26. M. J. Peck, P. J. Piper and T. J. Williams,The effect of leukotrienes C 4 and D4 on the microvasculature of guinea pig skin. Prostaglandins21, 315–321 (1981).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Janssen Research Foundation, B-2340, Beerse, Belgium

    J. P. van Wauwe & J. G. Goossens

Authors
  1. J. P. van Wauwe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. G. Goossens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Wauwe, J.P., Goossens, J.G. Arabinogalactan- and dextran-induced ear inflammation in mice: Differential inhibition by H1-antihistamines, 5-HT-serotonin antagonists and lipoxygenase blockers. Agents and Actions 28, 78–82 (1989). https://doi.org/10.1007/BF02022984

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02022984

Keywords

Search

Navigation